These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38158078)

  • 1. Role of Hepatic Stellate and Liver Sinusoidal Endothelial Cells in a Human Primary Cell Three-Dimensional Model of Nonalcoholic Steatohepatitis.
    Tan PK; Ostertag T; Rosenthal SB; Chilin-Fuentes D; Aidnik H; Linker S; Murphy K; Miner JN; Brenner DA
    Am J Pathol; 2024 Mar; 194(3):353-368. PubMed ID: 38158078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activin-A causes Hepatic stellate cell activation via the induction of TNFα and TGFβ in Kupffer cells.
    Kiagiadaki F; Kampa M; Voumvouraki A; Castanas E; Kouroumalis E; Notas G
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):891-899. PubMed ID: 29287776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depletion of Activated Hepatic Stellate Cells and Capillarized Liver Sinusoidal Endothelial Cells Using a Rationally Designed Protein for Nonalcoholic Steatohepatitis and Alcoholic Hepatitis Treatment.
    Mishra F; Yuan Y; Yang JJ; Li B; Chan P; Liu Z
    Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research progress of hepatic non-parenchymal cells in nonalcoholic steatohepatitis].
    Zheng TX; Li R; Tan P; Huang MZ; Qian BL; Chen H; Fu WW
    Zhonghua Gan Zang Bing Za Zhi; 2021 Jul; 29(7):711-715. PubMed ID: 34371545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
    Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
    J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Endothelial Necroptosis Disrupts Profibrotic Endothelial-Hepatic Stellate Cells Crosstalk to Alleviate Liver Fibrosis in Nonalcoholic Steatohepatitis.
    Yan M; Li H; Xu S; Wu J; Li J; Xiao C; Mo C; Ding BS
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of non‑parenchymal hepatocytes in the process of hepatic fibrosis (Review).
    Cheng QN; Yang X; Wu JF; Ai WB; Ni YR
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 3D primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates.
    Ströbel S; Kostadinova R; Fiaschetti-Egli K; Rupp J; Bieri M; Pawlowska A; Busler D; Hofstetter T; Sanchez K; Grepper S; Thoma E
    Sci Rep; 2021 Nov; 11(1):22765. PubMed ID: 34815444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease.
    Kimura T; Singh S; Tanaka N; Umemura T
    Front Endocrinol (Lausanne); 2021; 12():773432. PubMed ID: 34938271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group IVA Phospholipase A
    Kishinaka S; Kawashita E; Nishizaki T; Ishihara K; Akiba S
    Biol Pharm Bull; 2024; 47(5):1058-1065. PubMed ID: 38825533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant iron distribution via hepatocyte-stellate cell axis drives liver lipogenesis and fibrosis.
    Gao H; Jin Z; Bandyopadhyay G; Wang G; Zhang D; Rocha KCE; Liu X; Zhao H; Kisseleva T; Brenner DA; Karin M; Ying W
    Cell Metab; 2022 Aug; 34(8):1201-1213.e5. PubMed ID: 35921818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
    Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular vesicles derived from fat-laden hepatocytes undergoing chemical hypoxia promote a pro-fibrotic phenotype in hepatic stellate cells.
    Hernández A; Reyes D; Geng Y; Arab JP; Cabrera D; Sepulveda R; Solis N; Buist-Homan M; Arrese M; Moshage H
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165857. PubMed ID: 32512191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial group IVA phospholipase A
    Kawashita E; Ozaki T; Ishihara K; Kashiwada C; Akiba S
    Life Sci; 2022 Apr; 294():120355. PubMed ID: 35093339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic Stellate Cells: Dictating Outcome in Nonalcoholic Fatty Liver Disease.
    Wiering L; Subramanian P; Hammerich L
    Cell Mol Gastroenterol Hepatol; 2023; 15(6):1277-1292. PubMed ID: 36828280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis.
    Schwabe RF; Tabas I; Pajvani UB
    Gastroenterology; 2020 May; 158(7):1913-1928. PubMed ID: 32044315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine (CC-motif) receptor-like 2 mRNA is expressed in hepatic stellate cells and is positively associated with characteristics of non-alcoholic steatohepatitis in mice and men.
    Zimny S; Pohl R; Rein-Fischboeck L; Haberl EM; Krautbauer S; Weiss TS; Buechler C
    Exp Mol Pathol; 2017 Aug; 103(1):1-8. PubMed ID: 28600126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vsig4
    Li HY; Fu SW; Wu JC; Li ZH; Xu MY
    Inflamm Res; 2023 Apr; 72(4):669-682. PubMed ID: 36745210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Nonalcoholic Steatohepatitis on a Chip.
    Freag MS; Namgung B; Reyna Fernandez ME; Gherardi E; Sengupta S; Jang HL
    Hepatol Commun; 2021 Feb; 5(2):217-233. PubMed ID: 33553970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.